Epirubicin Hydrochloride Liposome (CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd)
盐酸表柔比星脂质体 (石药集团中奇制药技术（石家庄）有限公司)
Report date: 2025/05/29 15:39:55
Base Information
Drug NameEpirubicin Hydrochloride Liposome (CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A